AMST vs ASML

AMST exhibits severe financial distress despite strong revenue growth, as reflected in its critically low Piotroski F-Score of 1/9 and absence of an Altman Z-Score, indicating high bankruptcy risk. The company reports massive operating losses, negative ROE and ROA, and a gross margin that is artificially inflated by minimal cost structure, suggesting unsustainable profitability. While revenue growth is explosive at 746.8% YoY, it is not translating into earnings, and the stock trades at an extreme valuation (Price/Sales: 27.71) with no earnings support. The 52-week price range shows extreme volatility, and the 5-year return of -97.4% underscores long-term underperformance. Analyst coverage is absent, and insider activity is neutral, offering no conviction signal.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.